PRS26 Economic Evaluation of Omalizumab in Patients With Uncontrolled Severe Allergic Asthma From the Public Payer Perspective in Brazil
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.2025
https://www.valueinhealthjournal.com/article/S1098-3015(12)03738-2/fulltext
Title :
PRS26 Economic Evaluation of Omalizumab in Patients With Uncontrolled Severe Allergic Asthma From the Public Payer Perspective in Brazil
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03738-2&doi=10.1016/j.jval.2012.08.2025
First page :
A564
Section Title :
Respiratory-Related Disorders
Open access? :
No
Section Order :
1513